Literature DB >> 6224682

Bioassay procedures for norfloxacin.

J Bland, A Edison, J Huber.   

Abstract

A disk-diffusion bioassay procedure for the quantitation of norfloxacin in serum, tissue and urine employing Klebsiella pneumoniae ATCC 10031 was developed. When incubated at 28 degrees C, the assay has a sensitivity of 0.2 microgram/ml. Zones of inhibition on assay plates may be measured by hand (ruler, vernier caliper) or by automated image analysis. Urine samples require an initial 1:2 dilution in 0.1N HCl before assay to assure complete solution of the compound. Bioassay values in urine are comparable to those obtained by high performance liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224682     DOI: 10.1007/bf02029527

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  3 in total

1.  In vitro antibacterial activity of AM-715, a new nalidixic acid analog.

Authors:  A Ito; K Hirai; M Inoue; H Koga; S Suzue; T Irikura; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

2.  Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.

Authors:  V K Boppana; B N Swanson
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

3.  Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.

Authors:  K Hirai; A Ito; Y Abe; S Suzue; T Irikura; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

  3 in total
  3 in total

1.  Enoxacin penetration into human prostatic tissue.

Authors:  M G Bergeron; R Roy; C Lessard; P Foucault
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

2.  Norfloxacin penetration into human renal and prostatic tissues.

Authors:  M G Bergeron; M Thabet; R Roy; C Lessard; P Foucault
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

3.  Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.

Authors:  D Gargallo; M Moros; R Coll; M Esteve; J Parés; M A Xicota; J Guinea
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.